Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 92 | 34 | 57 | 84 | 107 |
| Gross Profit | 92 | 34 | 57 | 84 | 107 |
| Operating Expenses | 15,272 | 17,039 | 13,674 | 10,789 | 7,915 |
| Operating Income | -15,180 | -17,005 | -13,617 | -10,705 | -7,808 |
| Interest Expense | 122 | 0 | 0 | 0 | 0 |
| Other Income | 227 | 157 | 209 | 171 | 50 |
| Pre-tax Income | -15,075 | -16,848 | -13,408 | -10,534 | -7,758 |
| Net Income Continuous | -15,075 | -16,848 | -13,408 | -10,534 | -7,758 |
| Net Income | $-15,075 | $-16,848 | $-13,408 | $-10,534 | $-7,758 |
| EPS Basic Total Ops | -5.60 | -6.30 | -5.10 | -4.00 | -3.00 |
| EPS Basic Continuous Ops | -5.61 | -6.38 | -5.08 | -4.01 | -2.95 |
| EPS Diluted Total Ops | -5.60 | -6.30 | -5.10 | -4.00 | -3.00 |
| EPS Diluted Continuous Ops | -5.61 | -6.38 | -5.08 | -4.01 | -2.95 |
| EBITDA(a) | $-14,505 | $-16,379 | $-13,015 | $-10,357 | $-7,612 |